Ir a las transacciones
Salud

Prestige Inhome Care has found a long-term strategic partner

Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.

Established in 2005, Prestige Inhome Care is the leading in-home aged and NDIS care provider in Australia with over 1,800 clients, serviced by a team of more than 1,000 registered nurses and professional carers. Prestige provides first-class, premium care to its clientele across Victoria, NSW and Queensland, allowing them to stay in the comfort of their own home.

Oaklins’ team in Australia acted as corporate advisor to the shareholders of Prestige, who were seeking an investment partner to provide growth capital. The team worked closely alongside Prestige through a comprehensive investor roadshow process to find the right-fit investor to support Prestige’s future growth. The transaction adds to Oaklins’ track record advising founder-owned businesses on sourcing institutional growth capital and support that will help catapult the business to another level of success.

Contáctese con el equipo de la transacción

Scott McInnes

Director Ejecutivo
Melbourne, Australia
Oaklins Henslow

Ryan Whitelegg

Director Ejecutivo
Melbourne, Australia
Oaklins Henslow

Valentin Couleau

Director Asociado
Melbourne, Australia
Oaklins Henslow

George Fry

Director Asociado
Melbourne, Australia
Oaklins Henslow

Transacciones relacionadas

Backspin has completed a mandatory public tender offer for the shares of Spindox
Private Equity | TMT

Backspin has completed a mandatory public tender offer for the shares of Spindox

Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.

Aprenda más
Rare Patient Voice has been acquired by Konovo
Salud | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Aprenda más
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Salud

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Aprenda más